Ligand profile
PRH
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0519 — adenosine deaminase
Identifiers
Database identifiers and provenance.
- Ligand ID
PRH- PDB
1a4m- UniProt (similar protein)
P03958- Target protein
- VK055_0519
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 133.6
- −1 ≤ LogP ≤ 5 -2.83
- MW ≤ 500 Da 271.3
- LogP ≤ 5 -2.83
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 133.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1[nH+]c2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CN[C@H]2Oc1[nH+]c2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CN[C@H]2O
InChI=1S/C10H14N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,9-10,15-18H,1H2,(H,11,12)/p+1/t4-,6-,7-,9+,10-/m1/s1InChI=1S/C10H14N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,9-10,15-18H,1H2,(H,11,12)/p+1/t4-,6-,7-,9+,10-/m1/s1
WGRXVKRHIMUTPD-YOHZANMFSA-OWGRXVKRHIMUTPD-YOHZANMFSA-O
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00962
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PRH →
- PDB RCSB structure 1a4m →
- UniProt UniProt P03958 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PRH”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0519.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).